The role of IL-4+ memory T cells in SARS-CoV-2 booster vaccination
Authors:
- 30 August 2025
- journal article
- Published by Oxford University Press (OUP) in International Immunology
- Vol. 38 (1) , 41-55
Abstract
Vaccines effectively stimulate protective immune responses in healthy individuals, but the precise roles of germinal center (GC) and follicular helper T (TFH) cells in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine responses are not fully understood. This study used a conditional loss-of-function mouse model to investigate antibody responses to the Wuhan spike protein, specifically eliminating newly developed TFH cells during either the primary or memory phase. Our findings demonstrated that TFH-mediated GC responses are essential for primary vaccination. However, after booster immunization, memory B-cell responses were effectively regulated through extrafollicular mechanisms, independent of TFH cells. Ablating IL-4 receptor signaling in B cells attenuated antibody production in both the primary and memory phases, highlighting the critical role of IL-4 for optimal humoral immunity. We identified a unique population of IL-4-expressing memory T (IL-4+Tm) cells, characterized by CD27, GATA3, and IRF4 expression, that is strongly associated with these extrafollicular memory B-cell responses, capable of neutralizing SARS-CoV-2 variants. Furthermore, Omicron-based booster immunization recovered the immunity against emerging variants under TFH-deficient conditions. These results suggest that IL-4+Tm cells are an alternative pathway to sustain memory responses when GC function is impaired, particularly in immunocompromised states. Our study advances the understanding of memory T-cell-mediated humoral responses to SARS-CoV-2, offering insights for future vaccine strategies.Keywords
Funding Information
- AMED-CREST (19gm1310002)
This publication has 36 references indexed in Scilit:
- Spike recognition and neutralization of SARS-CoV-2 Omicron subvariants elicited after the third dose of mRNA vaccineCell Reports, 2023
- Potent SARS-CoV-2 neutralizing antibodies with therapeutic effects in two animal modelsiScience, 2022
- Humoral and cellular immune memory to four COVID-19 vaccinesCell, 2022
- Extrafollicular PD-1highCXCR5–CD4+ T cells participate in local immunoglobulin production in nasal polypsJournal of Allergy and Clinical Immunology, 2022
- The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathioneBiochemical and Biophysical Research Communications, 2022
- Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccinationCell, 2022
- Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease SeverityCell, 2020
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19Cell, 2020
- A Distinct Human CD4+ T Cell Subset That Secretes CXCL13 in Rheumatoid SynoviumArthritis & Rheumatism, 2013
- The elusive identity of T follicular helper cellsTrends in Immunology, 2010